BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2578312)

  • 1. Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures.
    Grosso LE; Pitot HC
    Cancer Res; 1985 Feb; 45(2):847-50. PubMed ID: 2578312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin structure of the c-myc gene in HL-60 cells during alterations of transcriptional activity.
    Grosso LE; Pitot HC
    Cancer Res; 1985 Oct; 45(10):5035-41. PubMed ID: 3861242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
    Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
    Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
    Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells.
    Filmus J; Buick RN
    Cancer Res; 1985 Feb; 45(2):822-5. PubMed ID: 3855381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased c-myc RNA levels associated with the precommitment state during HL-60 myeloid differentiation.
    Yen A; Guernsey DL
    Cancer Res; 1986 Aug; 46(8):4156-61. PubMed ID: 3460694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
    Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
    J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS; Baker VV; May WS
    Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H; Watanabe T; Nomura S; Oishi M
    Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA synthesis by an inducer of differentiation of leukemic cells, 1 alpha, 25 dihydroxy vitamin D3, precedes down regulation of the c-myc gene.
    Brelvi ZS; Studzinski GP
    J Cell Physiol; 1986 Aug; 128(2):171-9. PubMed ID: 3755442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
    Yen A; Forbes ME
    Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG; Antoun GR; Zipf TF
    Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
    Larsson LG; Pettersson M; Oberg F; Nilsson K; Lüscher B
    Oncogene; 1994 Apr; 9(4):1247-52. PubMed ID: 8134128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
    Stöcker U; Schaefer A; Marquardt H
    Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gene expression of myeloperoxidase during myeloid differentiation.
    Tobler A; Miller CW; Johnson KR; Selsted ME; Rovera G; Koeffler HP
    J Cell Physiol; 1988 Aug; 136(2):215-25. PubMed ID: 2842344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of irreversibility of granulocytic differentiation induced by dimethyl sulfoxide in HL-60 sublines with a homogeneously staining region.
    Kitajima K; Haque M; Nakamura H; Hirano T; Utiyama H
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1182-7. PubMed ID: 11700036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decrease of insulin binding to human acute leukemic cells during chemically induced differentiation].
    Palumbo A; Turco GL; Brossa C; D'Alberto M; Ghezzo F; Pegoraro L
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1350-4. PubMed ID: 7004463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.